Regenxbio Cash from Investing (TTM) Analysis

Regenxbio Inc (RGNX)

15.94 +0.27 (+1.72%) USD | NASDAQ | Apr 23, 14:18

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	190.94M
September 30, 2023	183.67M
June 30, 2023	198.06M
March 31, 2023	141.76M
December 31, 2022	-11.93M
September 30, 2022	-254.99M
June 30, 2022	-291.93M
March 31, 2022	-283.05M
December 31, 2021	-406.64M
September 30, 2021	-178.71M
June 30, 2021	-160.82M
March 31, 2021	-124.13M
December 31, 2020	122.76M
September 30, 2020	125.34M
June 30, 2020	143.62M
March 31, 2020	120.81M
December 31, 2019	93.56M

Date	Value
September 30, 2019	12.22M
June 30, 2019	-176.77M
March 31, 2019	-236.81M
December 31, 2018	-279.36M
September 30, 2018	-213.32M
June 30, 2018	-57.83M
March 31, 2018	-45.04M
December 31, 2017	-4.79M
September 30, 2017	13.79M
June 30, 2017	4.822M
March 31, 2017	33.29M
December 31, 2016	19.39M
September 30, 2016	-142.39M
June 30, 2016	-171.33M
March 31, 2016	-174.43M
December 31, 2015	-163.80M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-406.64M

Minimum

Dec 2021

198.06M

Maximum

Jun 2023

-29.28M

Average

12.22M

Median

Sep 2019

Cash from Investing (TTM) Benchmarks